Your session is about to expire
← Back to Search
Behavioral Intervention
Cognitive Training for Older Adults' Cognitive Health
N/A
Waitlist Available
Led By Hanzhang Xu, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Are age 60 or older
Have no self-reported diagnosis of ADRD or cognitive impairment, and are capable of making an informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 6 months
Awards & highlights
Study Summary
This trial will help create a phone-based intervention to help improve cognitive function for older Chinese-Americans.
Who is the study for?
This trial is for older Chinese Americans, aged 60 or above, who can see and hear well enough to use a smartphone or tablet. They should be fluent in Chinese and/or English, self-identify as Chinese, have no reported cognitive impairments or Alzheimer's disease-related dementias (ADRD), and must be able to consent. Those bed-ridden, undergoing chemotherapy for cancer, or with other life-threatening illnesses cannot participate.Check my eligibility
What is being tested?
The study aims to develop and test a mobile health (mHealth) app designed specifically for cognitive training that suits the cultural and linguistic needs of older Chinese Americans. The intervention involves using this app regularly over the course of the study.See study design
What are the potential side effects?
Since this trial focuses on cognitive training through an mHealth application, there are no direct medical side effects expected from participation. However, participants may experience eye strain or minor stress due to regular use of digital devices.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 60 years old or older.
Select...
I do not have any cognitive impairments and can make decisions for myself.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ approximately 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability as Measured by the Client Satisfaction Questionnaire
Change in Global cognition as a composite measure of Mini-Mental State Examination(MMSE), Digit Span Test, verbal fluency, and the Trail Making Test
Days of App use as Measured by the percentage of days that participants use the app
+5 moreSecondary outcome measures
Anxiety
Change in Depressive Symptoms as Measured by the Patient Health Questionnaire-9
Change in Loneliness as Measured by the University of California, Los Angeles three item Loneliness Scale
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive TrainingExperimental Treatment1 Intervention
Participants in the experimental arm will be provided a brochure that included information on basic knowledge of ADRD, signs and symptoms related to ADRD, the definition and the potential benefits of cognitively stimulating activities in maintaining cognitive function, and examples of cognitively stimulating activities.
Participants in this arm will complete a series of cognitive training exercises on a smartphone/tablet. The anticipated training will last for 12 weeks and involve 3-4 sessions per week (20-30 min/ session).
Group II: Passive ControlActive Control1 Intervention
A passive control group will be included in this pilot trial. Participants in this passive control arm will be provided a brochure that included information on basic knowledge of ADRD, signs and symptoms related to ADRD, the definition and the potential benefits of cognitively stimulating activities in maintaining cognitive function, and examples of cognitively stimulating activities.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Training Intervention
2014
N/A
~310
Find a Location
Who is running the clinical trial?
National Institute on Aging (NIA)NIH
1,668 Previous Clinical Trials
28,005,034 Total Patients Enrolled
1 Trials studying Cognitive Health
200 Patients Enrolled for Cognitive Health
Duke UniversityLead Sponsor
2,358 Previous Clinical Trials
3,420,039 Total Patients Enrolled
New York UniversityOTHER
226 Previous Clinical Trials
314,225 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not confined to bed.I am 60 years old or older.I do not have any cognitive impairments and can make decisions for myself.I am fluent in Chinese and/or English.I am currently undergoing chemotherapy for cancer.I do not have any other life-threatening illnesses.I can see and read a smartphone or tablet screen and hear normal speech.
Research Study Groups:
This trial has the following groups:- Group 1: Cognitive Training
- Group 2: Passive Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the principal objective of this clinical trial?
"This 12-week clinical trial will chiefly assess Days of App use through a percentage scale. Secondary metrics involve gauging Change in Loneliness via the UCLA three item loneliness scale (3 to ), measuring Physical Functioning with the Activities of Daily Living and Instrumental Activities of Daily Living Scale (14 to 52), as well as assessing Quality of Life using the World Health Organization Quality of Life Instrument- Abbreviated Version (0 to 100)."
Answered by AI
Is this clinical research still open to volunteer participants?
"This research project is no longer seeking new participants, as reported on clinicaltrials.gov; the protocol was first published in March of 2023 and last amended in October 2022. However, there are 6 alternative trials that currently require enrolment from prospective patients."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger